Evidence map›Paper›PMID 42626508›Full record

ArticleFrontiers in public health2026

Development of an early auxiliary diagnostic model for disseminated tuberculosis in HIV-negative tuberculosis patients.

Yicheng Guo, Xingyu Liu, Chen Yang, Shuanglin Gu, Weiwei Gao, Yi Zeng

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yicheng GuoDepartment of Tuberculosis, The School of Public Health of Nanjing Medical University, The Second Hospital of Nanjing, Nanjing, China.
Xingyu LiuDepartment of Tuberculosis, The Second Hospital of Nanjing, Nanjing, China.
Chen YangDepartment of Tuberculosis, The School of Public Health of Nanjing Medical University, The Second Hospital of Nanjing, Nanjing, China.
Shuanglin GuDepartment of Clinical Research Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China.
Weiwei GaoDepartment of Tuberculosis, The Second Hospital of Nanjing, Nanjing, China.
Yi ZengDepartment of Tuberculosis, The Second Hospital of Nanjing, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Disseminated tuberculosis (DI-TB) can induce multiple organ dysfunction syndrome and carries a high mortality rate. This study aimed to establish an early-warning diagnostic model to facilitate the identification of DI-TB high-risk patients and improve clinical prognosis. Methods: We retrospectively enrolled 1,122 HIV-negative hospitalized patients with disseminated tuberculosis (DI-TB) or pulmonary tuberculosis (PTB) admitted to Nanjing Second Hospital. Using conventional laboratory tests and multidimensional lymphocyte subset analysis, a diagnostic model was constructed employing machine learning algorithms. Feature importance analysis was performed using the Shapley Additive Explanations (SHAP) framework. Results: We screened nine significant features for model development. The XGB model demonstrated favorable diagnostic performance in the internal test set, achieving an AUC of 0.983, a Brier score of 0.025, an accuracy of 0.949, sensitivity of 0.914, specificity of 0.961, F1-score of 0.897, MCC of 0.864, NPV of 0.972, and PPV of 0.881. The SHAP interpretability system ranked features by importance, illustrating their positive or negative contributions to XGB predictions and explaining how individual features influenced model outputs. Conclusion: This study developed and internally evaluated a machine learning-enabled auxiliary risk-stratification model for identifying dissemination risk among HIV-negative hospitalized TB patients. The XGB model showed favorable internal performance and may provide a potential auxiliary tool for early DI-TB risk assessment, but prospective external validation is still required before routine clinical application.

Indexed as

Machine LearningTuberculosis, PulmonaryAdultChinaEarly DiagnosisFemaleHumansMaleMiddle AgedRetrospective Studiesdiagnostic algorithmdisseminated tuberculosisimmune indicatorsmachine learningmodel development

Identifiers

PMID42626508
PMCPMC13491642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.